Quarter after quarter for the past year, Takeda’s revenues have been bogged down by generic impacts to its stalwart ADHD med ...

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...

The comments come as Sanofi reported Thursday that its total vaccine sales fell 2.5% in the fourth quarter and 1.2% for the ...

Last year, Novartis debuted its first-ever Super Bowl ad with an aim of starting “a movement” around early breast cancer ...

The “Highlights REAL” campaign, which Bayer kicked off Thursday, stars Romo, who played for the Dallas Cowboys before ...

Roche is looking to a busy 2026 after 10 new molecules entered late-stage testing last year and as a potential launch of ...

With large pharma companies now confronting a two-pronged assault on U.S. | On Wednesday, the U.S. Chamber of Commerce filed an amicus brief calling on the Supreme Court to review a lower court ...

Last year, Hims & Hers put out a Super Bowl ad—the first for the telehealth giant—that sparked both support and outrage for the way it claimed that Big Pharma prices GLP-1s “ for profits, not patients ...

Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the ...

A few months after sending an untitled letter to ARS Pharmaceuticals, taking issue with certain aspects of a TV commercial about its epinephrine nasal spray, the FDA is reiterating its concerns about ...

Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...

Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.